Calithera Biosciences ^{Priced, Nasdaq: CALA}

Early-stage biotech developing a drug platform that inhibits tumor metabolism.

Industry: Health Care

First Day Return: -5.9%

CALA

Early-stage biotech developing a drug platform that inhibits tumor metabolism.

IPO News for Calithera Biosciences

US IPO Pricing Recap: 11 IPOs trade poorly but investors can't get enough American Addiction 10/03/14
Calithera Biosciences prices IPO at $10, below the range 10/02/14
11 IPOs planned for the week of September 29; 4th quarter kicks off with a $1 billion IPO 09/29/14

IPO Data
IPO Date	10/01/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$80
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Headquarters	South San Francisco, CA, United States
Founded	2010
Employees at IPO	36
Website www.calithera.com

IPO News for Calithera Biosciences

Calithera Biosciences (CALA) Performance